GlassScriptPhysician profile
Cody R Chambers
NPI 1386283679
$3,519.28
in general payments reported to CMS, 2019-2025
22 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,537 · 2022: $1,441 · 2023: $81.58 · 2024: $252 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $542.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $2,400.00 | 2021-2022 | |
| Depuy Synthes Sales INC. | $219.72 | 2021-2025 | Monovisc |
| Pacira Pharmaceuticals Incorporated | $152.34 | 2022-2025 | Exparel, Iovera, Zilretta |
| Nevro Corp. | $120.56 | 2021-2024 | Senza |
| Boston Scientific Corporation | $72.33 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $49.02 | 2022-2024 | Euflexxa |
| Vertex Pharmaceuticals Incorporated | $48.03 | 2025 | |
| Spinal Simplicity, LLC | $45.04 | 2021 | |
| Spr Therapeutics, INC | $43.31 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $41.88 | 2021 | |
| Pacira Therapeutics, INC. | $41.32 | 2021 | |
| Abbvie INC. | $40.44 | 2024 | |
| Collegium Pharmaceutical, INC. | $39.25 | 2021 | |
| Amgen INC. | $35.59 | 2021-2022 | |
| Stryker Corporation | $35.23 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $29.21 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Naviswiss, INC. | $27.54 | 2025 | Naviswiss Hip/Knee Navigation |
| Organogenesis INC. | $21.49 | 2024 | |
| Globus Medical, INC. | $19.69 | 2025 | Senza |
| Azurity Pharmaceuticals, INC. | $14.06 | 2023 | Horizant |
| Almatica Pharma LLC | $12.15 | 2021 | |
| Virtus Pharmaceuticals LLC | $11.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cody Chambers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.